Osteoporosis  ||| S:0 E:13 ||| NNP
in  ||| S:13 E:16 ||| IN
rheumatoid  ||| S:16 E:27 ||| JJ
arthritis  ||| S:27 E:37 ||| NN
and  ||| S:37 E:41 ||| CC
ankylosing  ||| S:41 E:52 ||| JJ
spondylitis  ||| S:52 E:64 ||| JJ
Bone  ||| S:64 E:69 ||| NNP
is  ||| S:69 E:72 ||| VBZ
a  ||| S:72 E:74 ||| DT
target  ||| S:74 E:81 ||| NN
in  ||| S:81 E:84 ||| IN
many  ||| S:84 E:89 ||| JJ
inflammatory  ||| S:89 E:102 ||| JJ
rheumatic  ||| S:102 E:112 ||| JJ
diseases ||| S:112 E:120 ||| NNS
,  ||| S:120 E:122 ||| ,
such  ||| S:122 E:127 ||| JJ
as  ||| S:127 E:130 ||| IN
rheumatoid  ||| S:130 E:141 ||| JJ
arthritis  ||| S:141 E:151 ||| NN
( ||| S:151 E:152 ||| -LRB-
RA ||| S:152 E:154 ||| NNP
)  ||| S:154 E:156 ||| -RRB-
and  ||| S:156 E:160 ||| CC
ankylosing  ||| S:160 E:171 ||| JJ
spondylitis  ||| S:171 E:183 ||| NNS
( ||| S:183 E:184 ||| -LRB-
AS ||| S:184 E:186 ||| NNP
) ||| S:186 E:187 ||| -RRB-
.  ||| S:187 E:189 ||| .
The  ||| S:189 E:193 ||| DT
generalized  ||| S:193 E:205 ||| JJ
effect  ||| S:205 E:212 ||| NN
of  ||| S:212 E:215 ||| IN
inflammation  ||| S:215 E:228 ||| NN
on  ||| S:228 E:231 ||| IN
bone  ||| S:231 E:236 ||| NN
may  ||| S:236 E:240 ||| MD
result  ||| S:240 E:247 ||| VB
in  ||| S:247 E:250 ||| IN
a  ||| S:250 E:252 ||| DT
decreased  ||| S:252 E:262 ||| JJ
quality  ||| S:262 E:270 ||| NN
of  ||| S:270 E:273 ||| IN
bone  ||| S:273 E:278 ||| NN
and  ||| S:278 E:282 ||| CC
is  ||| S:282 E:285 ||| VBZ
associated  ||| S:285 E:296 ||| VBN
with  ||| S:296 E:301 ||| IN
an  ||| S:301 E:304 ||| DT
increased  ||| S:304 E:314 ||| JJ
risk  ||| S:314 E:319 ||| NN
of  ||| S:319 E:322 ||| IN
fractures  ||| S:322 E:332 ||| NN
and  ||| S:332 E:336 ||| CC
deformities ||| S:336 E:347 ||| NN
,  ||| S:347 E:349 ||| ,
both  ||| S:349 E:354 ||| DT
in  ||| S:354 E:357 ||| IN
RA  ||| S:357 E:360 ||| NNP
and  ||| S:360 E:364 ||| CC
AS ||| S:364 E:366 ||| NNP
.  ||| S:366 E:368 ||| .
RA  ||| S:368 E:371 ||| NNP
is  ||| S:371 E:374 ||| VBZ
characterized  ||| S:374 E:388 ||| VBN
by  ||| S:388 E:391 ||| IN
periarticular  ||| S:391 E:405 ||| JJ
osteopenia ||| S:405 E:415 ||| NN
,  ||| S:415 E:417 ||| ,
systemic  ||| S:417 E:426 ||| JJ
osteoporosis  ||| S:426 E:439 ||| NN
and  ||| S:439 E:443 ||| CC
bone  ||| S:443 E:448 ||| NN
erosions ||| S:448 E:456 ||| NN
.  ||| S:456 E:458 ||| .
Periarticular  ||| S:458 E:472 ||| JJ
osteopenia  ||| S:472 E:483 ||| NN
and  ||| S:483 E:487 ||| CC
bone  ||| S:487 E:492 ||| NN
erosions  ||| S:492 E:501 ||| NNS
are  ||| S:501 E:505 ||| VBP
mainly  ||| S:505 E:512 ||| RB
correlated  ||| S:512 E:523 ||| VBN
with  ||| S:523 E:528 ||| IN
disease  ||| S:528 E:536 ||| NN
activity ||| S:536 E:544 ||| NN
.  ||| S:544 E:546 ||| .
Unlike  ||| S:546 E:553 ||| IN
postmenopausal  ||| S:553 E:568 ||| JJ
osteoporosis ||| S:568 E:580 ||| NN
,  ||| S:580 E:582 ||| ,
osteoporosis  ||| S:582 E:595 ||| VBG
in  ||| S:595 E:598 ||| IN
RA  ||| S:598 E:601 ||| NNP
is  ||| S:601 E:604 ||| VBZ
more  ||| S:604 E:609 ||| JJR
characterised  ||| S:609 E:623 ||| NN
by  ||| S:623 E:626 ||| IN
marked  ||| S:626 E:633 ||| JJ
loss  ||| S:633 E:638 ||| NN
of  ||| S:638 E:641 ||| IN
bone  ||| S:641 E:646 ||| NN
in  ||| S:646 E:649 ||| IN
the  ||| S:649 E:653 ||| DT
hip  ||| S:653 E:657 ||| NN
and  ||| S:657 E:661 ||| CC
the  ||| S:661 E:665 ||| DT
radius ||| S:665 E:671 ||| NN
,  ||| S:671 E:673 ||| ,
while  ||| S:673 E:679 ||| IN
the  ||| S:679 E:683 ||| DT
axial  ||| S:683 E:689 ||| JJ
bone  ||| S:689 E:694 ||| NN
is  ||| S:694 E:697 ||| VBZ
relatively  ||| S:697 E:708 ||| RB
preserved ||| S:708 E:717 ||| VBN
.  ||| S:717 E:719 ||| .
In  ||| S:719 E:722 ||| IN
general ||| S:722 E:729 ||| JJ
,  ||| S:729 E:731 ||| ,
several  ||| S:731 E:739 ||| JJ
cross-sectional  ||| S:739 E:755 ||| JJ
studies  ||| S:755 E:763 ||| NNS
documented  ||| S:763 E:774 ||| VBN
a  ||| S:774 E:776 ||| DT
lower  ||| S:776 E:782 ||| JJR
bone  ||| S:782 E:787 ||| NN
mineral  ||| S:787 E:795 ||| NN
density  ||| S:795 E:803 ||| NN
in  ||| S:803 E:806 ||| IN
patients  ||| S:806 E:815 ||| NNS
with  ||| S:815 E:820 ||| IN
RA ||| S:820 E:822 ||| NNP
,  ||| S:822 E:824 ||| ,
with  ||| S:824 E:829 ||| IN
a  ||| S:829 E:831 ||| DT
two-fold  ||| S:831 E:840 ||| JJ
increase  ||| S:840 E:849 ||| NN
in  ||| S:849 E:852 ||| IN
osteoporosis  ||| S:852 E:865 ||| VBG
compared  ||| S:865 E:874 ||| VBN
to  ||| S:874 E:877 ||| TO
age-  ||| S:877 E:882 ||| JJ
and  ||| S:882 E:886 ||| CC
sex-matched  ||| S:886 E:898 ||| JJ
controls  ||| S:898 E:907 ||| NNS
and  ||| S:907 E:911 ||| CC
relates  ||| S:911 E:919 ||| VBZ
to  ||| S:919 E:922 ||| TO
an  ||| S:922 E:925 ||| DT
increased  ||| S:925 E:935 ||| JJ
fracture  ||| S:935 E:944 ||| JJ
risk ||| S:944 E:948 ||| NN
.  ||| S:948 E:950 ||| .
Several  ||| S:950 E:958 ||| JJ
factors  ||| S:958 E:966 ||| NNS
contribute  ||| S:966 E:977 ||| VBP
to  ||| S:977 E:980 ||| TO
the  ||| S:980 E:984 ||| DT
increased  ||| S:984 E:994 ||| JJ
risk ||| S:994 E:998 ||| NN
:  ||| S:998 E:1000 ||| :
older  ||| S:1000 E:1006 ||| JJR
age ||| S:1006 E:1009 ||| NN
,  ||| S:1009 E:1011 ||| ,
little  ||| S:1011 E:1018 ||| JJ
exercise ||| S:1018 E:1026 ||| NN
,  ||| S:1026 E:1028 ||| ,
long-term  ||| S:1028 E:1038 ||| JJ
use  ||| S:1038 E:1042 ||| NN
of  ||| S:1042 E:1045 ||| IN
corticosteroids ||| S:1045 E:1060 ||| NN
,  ||| S:1060 E:1062 ||| ,
and  ||| S:1062 E:1066 ||| CC
high  ||| S:1066 E:1071 ||| JJ
disability  ||| S:1071 E:1082 ||| NN
index ||| S:1082 E:1087 ||| NN
.  ||| S:1087 E:1089 ||| .
AS  ||| S:1089 E:1092 ||| RB
is  ||| S:1092 E:1095 ||| VBZ
characterized  ||| S:1095 E:1109 ||| VBN
by  ||| S:1109 E:1112 ||| IN
an  ||| S:1112 E:1115 ||| DT
increase  ||| S:1115 E:1124 ||| NN
in  ||| S:1124 E:1127 ||| IN
bone  ||| S:1127 E:1132 ||| NN
fragility  ||| S:1132 E:1142 ||| NN
due  ||| S:1142 E:1146 ||| JJ
to  ||| S:1146 E:1149 ||| TO
reduced  ||| S:1149 E:1157 ||| JJ
bone  ||| S:1157 E:1162 ||| NN
mineral  ||| S:1162 E:1170 ||| NN
density ||| S:1170 E:1177 ||| NN
.  ||| S:1177 E:1179 ||| .
The  ||| S:1179 E:1183 ||| DT
reported  ||| S:1183 E:1192 ||| JJ
prevalence  ||| S:1192 E:1203 ||| NN
of  ||| S:1203 E:1206 ||| IN
osteoporosis  ||| S:1206 E:1219 ||| NN
in  ||| S:1219 E:1222 ||| IN
AS  ||| S:1222 E:1225 ||| NNP
patients  ||| S:1225 E:1234 ||| NNS
varies  ||| S:1234 E:1241 ||| VBZ
largely ||| S:1241 E:1248 ||| RB
.  ||| S:1248 E:1250 ||| .
The  ||| S:1250 E:1254 ||| DT
large  ||| S:1254 E:1260 ||| JJ
variation  ||| S:1260 E:1270 ||| NN
reflects  ||| S:1270 E:1279 ||| VBZ
the  ||| S:1279 E:1283 ||| DT
difficulties  ||| S:1283 E:1296 ||| NNS
in  ||| S:1296 E:1299 ||| IN
assessing  ||| S:1299 E:1309 ||| VBG
BMD  ||| S:1309 E:1313 ||| NNP
in  ||| S:1313 E:1316 ||| IN
AS  ||| S:1316 E:1319 ||| NNP
due  ||| S:1319 E:1323 ||| JJ
to  ||| S:1323 E:1326 ||| TO
new  ||| S:1326 E:1330 ||| JJ
bone  ||| S:1330 E:1335 ||| NN
formation ||| S:1335 E:1344 ||| NN
.  ||| S:1344 E:1346 ||| .
Bone  ||| S:1346 E:1351 ||| JJ
fragility  ||| S:1351 E:1361 ||| NN
is  ||| S:1361 E:1364 ||| VBZ
also  ||| S:1364 E:1369 ||| RB
due  ||| S:1369 E:1373 ||| JJ
to  ||| S:1373 E:1376 ||| TO
changes  ||| S:1376 E:1384 ||| NNS
in  ||| S:1384 E:1387 ||| IN
structural  ||| S:1387 E:1398 ||| JJ
properties  ||| S:1398 E:1409 ||| NNS
resulting  ||| S:1409 E:1419 ||| VBG
from  ||| S:1419 E:1424 ||| IN
inflammation-induced  ||| S:1424 E:1445 ||| JJ
bone  ||| S:1445 E:1450 ||| NN
failure  ||| S:1450 E:1458 ||| NN
in  ||| S:1458 E:1461 ||| IN
the  ||| S:1461 E:1465 ||| DT
spine  ||| S:1465 E:1471 ||| NN
in  ||| S:1471 E:1474 ||| IN
combination  ||| S:1474 E:1486 ||| NN
with  ||| S:1486 E:1491 ||| IN
reduced  ||| S:1491 E:1499 ||| JJ
capacity  ||| S:1499 E:1508 ||| NN
of  ||| S:1508 E:1511 ||| IN
shock  ||| S:1511 E:1517 ||| NN
absorption  ||| S:1517 E:1528 ||| VBZ
leading  ||| S:1528 E:1536 ||| VBG
to  ||| S:1536 E:1539 ||| TO
vertebral  ||| S:1539 E:1549 ||| VB
fractures ||| S:1549 E:1558 ||| NNS
.  ||| S:1558 E:1560 ||| .
Different  ||| S:1560 E:1570 ||| JJ
types  ||| S:1570 E:1576 ||| NNS
of  ||| S:1576 E:1579 ||| IN
spinal  ||| S:1579 E:1586 ||| JJ
fractures  ||| S:1586 E:1596 ||| NN
in  ||| S:1596 E:1599 ||| IN
patients  ||| S:1599 E:1608 ||| NNS
with  ||| S:1608 E:1613 ||| IN
AS  ||| S:1613 E:1616 ||| NNP
are  ||| S:1616 E:1620 ||| VBP
described ||| S:1620 E:1629 ||| VBN
,  ||| S:1629 E:1631 ||| ,
including  ||| S:1631 E:1641 ||| VBG
wedging ||| S:1641 E:1648 ||| NNS
.  ||| S:1648 E:1650 ||| .
Wedging  ||| S:1650 E:1658 ||| JJ
vertebral  ||| S:1658 E:1668 ||| JJ
fractures  ||| S:1668 E:1678 ||| NNS
contribute  ||| S:1678 E:1689 ||| VBP
to  ||| S:1689 E:1692 ||| TO
hyperkyphosis  ||| S:1692 E:1706 ||| VB
and  ||| S:1706 E:1710 ||| CC
impaired  ||| S:1710 E:1719 ||| JJ
physical  ||| S:1719 E:1728 ||| JJ
function ||| S:1728 E:1736 ||| NN
.  ||| S:1736 E:1738 ||| .
In  ||| S:1738 E:1741 ||| IN
contrast  ||| S:1741 E:1750 ||| NN
to  ||| S:1750 E:1753 ||| TO
RA  ||| S:1753 E:1756 ||| NNP
,  ||| S:1756 E:1758 ||| ,
bone  ||| S:1758 E:1763 ||| NN
loss  ||| S:1763 E:1768 ||| NN
in  ||| S:1768 E:1771 ||| IN
AS  ||| S:1771 E:1774 ||| NNP
is  ||| S:1774 E:1777 ||| VBZ
accompanied  ||| S:1777 E:1789 ||| VBN
by  ||| S:1789 E:1792 ||| IN
new  ||| S:1792 E:1796 ||| JJ
bone  ||| S:1796 E:1801 ||| NN
formation ||| S:1801 E:1810 ||| NN
.  ||| S:1810 E:1812 ||| .
The  ||| S:1812 E:1816 ||| DT
pathophysiology  ||| S:1816 E:1832 ||| NN
of  ||| S:1832 E:1835 ||| IN
osteoporosis  ||| S:1835 E:1848 ||| NN
in  ||| S:1848 E:1851 ||| IN
RA  ||| S:1851 E:1854 ||| NNP
and  ||| S:1854 E:1858 ||| CC
AS  ||| S:1858 E:1861 ||| NNP
probably  ||| S:1861 E:1870 ||| RB
is  ||| S:1870 E:1873 ||| VBZ
fundamentally  ||| S:1873 E:1887 ||| RB
similar ||| S:1887 E:1894 ||| JJ
,  ||| S:1894 E:1896 ||| ,
but  ||| S:1896 E:1900 ||| CC
with  ||| S:1900 E:1905 ||| IN
different  ||| S:1905 E:1915 ||| JJ
clinical  ||| S:1915 E:1924 ||| JJ
phenotypes ||| S:1924 E:1934 ||| NN
.  ||| S:1934 E:1936 ||| .
The  ||| S:1936 E:1940 ||| DT
implications  ||| S:1940 E:1953 ||| NNS
for  ||| S:1953 E:1957 ||| IN
therapeutically  ||| S:1957 E:1973 ||| JJ
intervening  ||| S:1973 E:1985 ||| NN
in  ||| S:1985 E:1988 ||| IN
its  ||| S:1988 E:1992 ||| PRP$
occurrence  ||| S:1992 E:2003 ||| NN
and  ||| S:2003 E:2007 ||| CC
progression  ||| S:2007 E:2019 ||| NNS
might  ||| S:2019 E:2025 ||| MD
be  ||| S:2025 E:2028 ||| VB
fundamentally  ||| S:2028 E:2042 ||| RB
different ||| S:2042 E:2051 ||| JJ
.  ||| S:2051 E:2053 ||| .
